Monday, December 23, 2024
HomeTagsDrugmaker Eli Lilly

Drugmaker Eli Lilly

ADDF Statement on FDA Decision Not to Grant Accelerated Approval to Donanemab for Treatment of Alzheimer’s Disease

Drugmaker Eli Lilly & Co announced that the FDA has issued a complete response letter, meaning it has not granted accelerated approval for amyloid-clearing...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics